Cornileus Pharmaceuticals Private Limited

Cornileus Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG2001PTC038288 Incorporated 28 December 2001 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2026
₹32.17 Cr
▲ 76% YoY
Net profit · FY 2026
₹70.44 Lakh
Net margin 2.2%
EBITDA · FY 2026
₹4.52 Cr
EBITDA margin 14%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.59 Cr
Issued & subscribed
Open charges
₹17 Cr
Satisfied ₹66.56 Cr
Company age
25 yrs
Est. 2001
Employees · EPFO
124
Provident fund records

About Cornileus Pharmaceuticals Private Limited

Data last updated:

Cornileus Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 28 December 2001 and has been in existence for over 25 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2001PTC038288. Its GSTIN is 36AABCC6487H1ZF (Telangana). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.59 Cr. It is led by directors including Kiran Kumar Nalamothu (Managing Director) and Jagarlamudi Suresh Babu.

Its last annual general meeting (AGM) was held on 01 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at H.No:1 – 98/V/103 Flat No.103 Plot No.17&18 Vishnu Avenues Krithika Layout Madhapur, Hyderabad, Telangana, India – 500081.

As per the financials filed for FY 2026, the company reported a revenue of ₹32.17 Cr, a growth of 76% compared to the previous year. For the same year it recorded a net profit of ₹70.44 Lakh (net margin 2.2%) and EBITDA of ₹4.52 Cr (EBITDA margin 14%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 21% over five years.

The company has about 124 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Cornileus Pharmaceuticals. As per MCA filings, the company has open charges of ₹17 Cr and satisfied charges of ₹66.56 Cr on record. Court records list 12 cases involving the company, including 9 filed by the company and 3 filed against it; 2 cases are pending.

Cornileus Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0007329). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cornileus.com.

Company details

CIN U24239TG2001PTC038288
Registration Number 038288
Incorporation Date 28 December 2001
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 01 August 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AP-10-0007329

CIN history

Cornileus Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2001PTC038288. The current CIN is U24239TG2001PTC038288, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG2001PTC038288Current
U24239AP2001PTC038288Previous
Key People
Kiran Kumar Nalamothu Managing Director Jagarlamudi Suresh Babu Director Venkat Samraj Jagarlamudi Director

Recognitions & Rankings of Cornileus Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-AP-10-0007329

Contact details

Cornileus Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is cornileus.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    cornileus.com
  • Social Media
  • Registered Address
    H.No:1 – 98/V/103 Flat No.103 Plot No.17&18 Vishnu Avenues Krithika Layout Madhapur, Hyderabad, Telangana, India – 500081
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Cornileus Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Cornileus Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Cornileus Pharmaceuticals operates one associated brand: Cornileus Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Cornileus Pharmaceuticals
Pharmaceutical research, manufacturing, and marketing of pellets and spheres in India with global operations.cornileus.com

Business activity

The main business activity of Cornileus Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Cornileus Pharmaceuticals Private Limited, buy the company report.

Financials of Cornileus Pharmaceuticals Private Limited

FY 2026 filings available

Cornileus Pharmaceuticals Private Limited reported revenue of ₹32.17 Cr (up 76% YoY) for FY 2026.

Revenue · FY 2026
₹32.17 Cr ▲ 76%
Net profit · FY 2026
₹70.44 Lakh margin 2.2%
EBITDA · FY 2026
₹4.52 Cr margin 14%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 76%
3 years · compounded
▼ 7%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▼ 21%
5 years · compounded
▼ 3%

Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 76% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹32.17 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.52 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹70.44 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin14%
Net Profit Margin2.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Cornileus Pharmaceuticals Private Limited, buy the company report.

Board of directors of Cornileus Pharmaceuticals Private Limited

Cornileus Pharmaceuticals has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jagarlamudi Suresh Babu
Also directs: Sakar Agritech LLP, Snap Grab LLP, Natsol Laboratories Private Limited and 2 more
Director28 Dec 20205 Years 10 MonthsCurrent
Kiran Kumar Nalamothu
Also directs: Regius Pharma LLP
Managing Director05 Nov 20188 Years 0 MonthsCurrent
Venkat Samraj Jagarlamudi
Also directs: Sakar Dairy LLP
Director28 Dec 20205 Years 10 MonthsCurrent
Vijayalakshmi Nalamothu
Also directs: Regius Pharma LLP
Director17 Oct 20179 Years 0 MonthsCurrent
View all directors

Auditor

Cornileus Pharmaceuticals Private Limited is audited by R.B.ASSOCIATES for the financial year 2026.

Auditor firmFinancial yearFirm registration number
R.B.ASSOCIATESFY 2026009112S

Shareholding

The shareholding of Cornileus Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Cornileus Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹17 Cr
Satisfied charges
₹66.56 Cr
Breakdown by lending institutions
Others₹17.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 May 2024100924158Others₹7.5 CrOpen
01 Feb 2019100238506Others₹9.5 CrOpen
07 Feb 2020100326337State Bank of India₹31.71 CrSatisfied
25 Sep 201310454812Andhra Bank₹1 CrSatisfied
23 Aug 201110310140Andhra Bank₹3 CrSatisfied

To see the full charge records of Cornileus Pharmaceuticals Private Limited, buy the company report.

Total charge records: 9 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Cornileus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Cornileus Pharmaceuticals Private Limited has a workforce of 124 employees on its EPFO records as of Mar 29, 2024, across 2 active EPFO establishments.

Employee count
124
Active EPFO establishments
2
Employee growth
6.9%

GST

Cornileus Pharmaceuticals has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
36AABCC6487H1ZFTelanganaActive01 Jul 2017
37AABCC6487H1ZDAndhra PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Cornileus Pharmaceuticals Private Limited, buy the company report.

Recent activity

Cornileus Pharmaceuticals Private Limited has 13 board changes on record since 2011: 4 appointments and 9 cessations. The latest: Jagarlamudi Suresh Babu ceased to be Additional Director on 25 Oct 2021.

Filing
Cornileus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Hyderabad.
AGM
Cornileus Pharmaceuticals Private Limited last Annual general meeting of members was held on 01 Aug 2025 as per latest MCA records.
Charges
A charge registered on 07 Feb 2020 via Charge ID 100326337 with State Bank Of India was fully satisfied on 20 Jun 2025.
Charges
A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100924158 was registered on 06 May 2024.
Charges
A charge with Others of Rs. 9.50 Cr registered on 01 Feb 2019 with Charge ID 100238506 was modified on 20 Sep 2022.
Ceased
Jagarlamudi Suresh Babu ceased to be Additional Director.
Ceased
Venkat Samraj Jagarlamudi ceased to be Additional Director.
Appointed
Jagarlamudi Suresh Babu was appointed as Director.
Ceased
Sampath Kumar Kandukuri ceased to be Director.
Appointed
Venkat Samraj Jagarlamudi was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 31.71 Cr registered on 07 Feb 2020 with Charge ID 100326337 was modified on 12 Aug 2020.
Charges
A charge with State Bank Of India amounted to Rs. 31.71 Cr with Charge ID 100326337 was registered on 07 Feb 2020.

25 earlier events are in the company report.

Frequently asked questions

Cornileus Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 28 December 2001 (25+ years old) and is registered under CIN U24239TG2001PTC038288.

Cornileus Pharmaceuticals has 4 current directors:

The latest financial statements of Cornileus Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 01 August 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Cornileus Pharmaceuticals is 36AABCC6487H1ZF, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AABCC6487H1ZD (Andhra Pradesh).

The CIN (Corporate Identification Number) of Cornileus Pharmaceuticals is U24239TG2001PTC038288. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Cornileus Pharmaceuticals has 12 court cases on record: 9 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.

Cornileus Pharmaceuticals was incorporated on 28 December 2001, making it 25+ years old. It is registered with the Registrar of Companies, Hyderabad.

Jagarlamudi Suresh Babu ceased to be Additional Director on 25 Oct 2021. Venkat Samraj Jagarlamudi ceased to be Additional Director on 25 Oct 2021. Jagarlamudi Suresh Babu was appointed as Director on 28 Dec 2020. Cornileus Pharmaceuticals has 13 board changes on record in total.

Yes, Cornileus Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-AP-10-0007329).

Cornileus Pharmaceuticals can be reached through the website cornileus.com. Its registered office is in Hyderabad, Telangana, India.